The Cannigma

OCTOBER 11, 2021

The majority of people who use the cannabinoid cannabigerol (CBG) for medical reasons find it to be helpful or very helpful in treating a variety of health conditions, according to the findings of a recent survey. No clinical trial was used in the compilation of the study. who have used it to treat anxiety.

Conditions 132

Conditions Clinical Trials Chronic Pain Cannabinoids 132

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

Cannabis Law Report

JUNE 29, 2021

We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools. Ehave, Inc.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

NORML

JANUARY 31, 2019

Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Twenty percent of those surveyed acknowledged having previously used cannabis for medical purposes.

Clinical Trials 211

Clinical Trials Chronic Pain Data Treatment 211

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Los Angeles, California. www.InvestorBrandNetwork.com. 310.299.1717 Office.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523. Strict Guidelines Must be Met Before Conditions Will Be Considered.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Cannabis Law Report

JULY 19, 2021

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. References Staff, T.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

FEBRUARY 27, 2022

“Securing Clinical Trial Authorisation solidifies over 16 months of hard work and dedication from our team and positions Halucenex as one of very few Canadian companies with approval to commence a clinical trial utilising psychedelic substances on mental health conditions,” president, CEO and founder Bill Fleming said.

Clinical Trials 52

Clinical Trials Data Treatment Conditions 52

MMJ Recs

DECEMBER 28, 2023

As the medical community delves into the therapeutic potential of cannabis, certain health conditions have emerged as primary candidates for its prescription. THC, the psychoactive component of cannabis, has analgesic properties that can help manage chronic pain conditions, such as neuropathic pain and arthritis.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

OCTOBER 26, 2021

The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinical trials. If these trials are successful and IHL-42X is approved for the market, Procaps will also make IHL-42X for patients.

Clinical Trials 52

Clinical Trials Sleep Medicine Pharmaceutical 52

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Cannabis Law Report

AUGUST 13, 2021

Development is underway with clinical trials expected to begin in the second half of 2022. “SalA is a great product candidate that magnificently matches the criteria we strive for, with recognized synergies across the atai platform.”.

Conditions 105

Conditions Research and Development Clinical Trials Treatment 105

Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For many other people of all ages, tinnitus is indeed a chronic condition that has nothing to do with loud ‘80s cover bands in small clubs. And it’s not just ringing.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Veriheal

JULY 18, 2023

Notably, the grant program will target three prevalent and often debilitating conditions in military personnel: PTSD, traumatic brain injury (TBI) , and chronic traumatic encephalopathy (CTE). This could foster a pool of experts well-versed in applying psychedelic-assisted therapy.

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. About the Opioid Epidemic. I don’t think it works for severe pain. Together, they work very well.

Clinical Trials 116

Clinical Trials Chronic Pain Hydroponic Strains 116

CannaMD

MARCH 30, 2022

While there have yet to be conclusive clinical trials defining the benefits of cannabis for Parkinson’s disease, these results indicate that many patients are finding relief with marijuana. More than 70% of people with Parkinson’s disease use marijuana to treat their symptoms, according to a recent survey.

Patients 98

Patients Clinical Trials Cannabis Marijuana 98

LifeCannMD

JULY 3, 2024

Various clinical trials are investigating the effectiveness of cannabis and its components in treating PTSD symptoms. Many patients report significant improvements in their PTSD symptoms with cannabis use and Florida has listed PTSD as a qualifying condition in order to obtain a Medical Marijuana card.

Treatment 96

Treatment Clinical Trials Marijuana Sleep 96

FloridaMarijuana.net

AUGUST 15, 2018

Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Cannabis Law Report

SEPTEMBER 2, 2021

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. Prohibition Partners has identified at least 30 late-stage clinical trials using cannabinoid therapeutics, any of which will probably have a large impact on the medicinal cannabis space.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Cannabinoids 105

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. What’s more, over the coming years psychedelics will continue to gain acceptance for treating these conditions which will also contribute to that market growth.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Cannabis Law Report

AUGUST 2, 2021

capital markets, negative global economic conditions, potential negative developments in our clinical trials or research programs, other negative developments in our business, or unfavorable legislative or regulatory developments. Each ADS would represent a certain number of fully paid ordinary shares in Bionomics.

Clinical Trials 105

Clinical Trials Research and Development Treatment Conditions 105

The Cannigma

MARCH 7, 2022

CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. What can the current clinical trials tell us?

THC 139

THC Sleep Clinical Trials Cannabinoids 139

FloridaMarijuana.net

AUGUST 15, 2018

A January 2018 Scientific American article titled “As Vets Demand Cannabis for PTSD, Science Races to Unlock Its Secrets” details a 2009 clinical trial in Canada which showed that the nighttime administration of THC reduced the frequency and intensity of nightmares in 72 percent of the 47 patients studied.”.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Cannabis Law Report

AUGUST 22, 2021

Company has also initiated preclinical studies aimed at treating psychologic and neurologic conditions. PsyBio intends to continue utilizing its resources to rapidly develop and test new drug candidates within this and other psychedelic categories in anticipation of launching future clinical trials.

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Project CBD

FEBRUARY 27, 2023

Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinical trials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. It’s not a new idea. That seemed to make all the difference.

THC 144

THC CBD Clinical Trials Sleep 144

LifeCannMD

JANUARY 31, 2025

#image_title Families affected by Huntington’s Disease (HD) know to well that this hereditary neurodegenerative condition progressively impacts movement, cognition, and behavior, profoundly affecting both patients and their loved ones. The post Cannabis in Neurodegenerative Conditions: Hope for Huntingtons Disease?

Conditions 52

Conditions Research and Development Cannabinoids Sleep 52

Veriheal

JUNE 29, 2022

While 233 participants might sound low, it is still the largest number of humans to participate in a psilocybin-based clinical trial. It’s rare to see such positive outcomes of clinical trials in this disease area, which is why these results are so significant.

Clinical Trials 105

Clinical Trials Blood Pressure Treatment Therapy 105

Veriheal

FEBRUARY 9, 2023

A fascinating new clinical trial demonstrates how this psychedelic compound could make people significantly more comfortable while undergoing MRIs or similar procedures. However, it is important to note that the study took place with a small sample size under controlled conditions. What Is an MRI?

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. There’s a condition that we call GERD, gastroesophageal reflux disease. there’s been a great deal of promotion of CBD for a wide variety of conditions.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

CannaMD

APRIL 23, 2020

Michael Farley , the President and Director of GBS Global Biopharma, the Canadian wing of GB Sciences, spoke to the study’s implications for the future: We look forward to bringing these promising formulations into human clinical trials as early as 2020. FDA in order to enter human clinical trial as early as this year!

Clinical Trials 116

Clinical Trials Research and Development Marijuana Treatment 116

Project CBD

MAY 3, 2023

CannMed: For what conditions do you think CBG has the most promise? Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin. It can be a very difficult condition. But we may be on the cusp of having those trials, which would be very exciting.

Cannabinoids 213

Cannabinoids Sleep Clinical Trials CBD 213

Cannabis Law Report

DECEMBER 15, 2021

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. “I agree with the committee that the preliminary findings from clinical trials — although still in early phases — evaluated by the panel are promising,” the decision’s author said.

Clinical Trials 52

Clinical Trials Conditions Supply Chain Environment 52

Cannabis Law Report

AUGUST 3, 2021

There is no assurance that the use of psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceuticals can diagnose, treat, cure or prevent any disease or condition. Vigorous scientific research and clinical trials are needed.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

The Cannigma

MAY 19, 2021

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 137

Law Legalization Clinical Trials CBD 137